Check where you can access Our Future Health data
Researchers can access Our Future Health data from many countries and territories.
Before you apply to become a researcher with us, check whether you can access Our Future Health data from each country or territory where you plan to work.
This access requirement is part of our eligible organisations policy (PDF only, 217 KB)
What the data access statuses mean
- Accepted: You can access Our Future Health data from this country or territory.
- Not accepted: You cannot access Our Future Health data from this country or territory. If you only plan to access the data from countries or territories listed as Not accepted, please do not submit a researcher application. We will not be able to give you access to the data. If you plan to access the data from both Accepted and Not accepted countries or territories, you can still apply. Our team will review your application.
- Under review: We’re reviewing whether you can access Our Future Health data from this country or territory. You can still apply while we complete our review.
- Not listed: We have not yet reviewed this country or territory. You can still apply and we’ll review whether you can access the data from there.
- Requires review by NHS England: You can access Our Future Health data from this country or territory. If your study also requests NHS England data, NHS England will need to complete a separate review before you can access their data.
You can check this page again in the future to see if the status has changed.
If a country or territory is Accepted but does not have an adequacy decision, you’ll need an International Data Transfer Agreement (IDTA). Find the guide to International Transfers (opens in new tab)
Countries with partial adequacy in place
Canada
Partial adequacy - only covers data that is subject to Canada's Personal Information Protection and Electronic Documents Act (PIPEDA). Not all data is subject to PIPEDA. ICO guidance states that an adequacy decision in place if data is processed in the course of ‘commercial activity’. Institutions should consider whether they consider themselves subject to the Canadian Personal Information Protection and Electronic Documents Act (PIPEDA) regarding their access to TRE data. Please read the guidance on the scope of PIPEDA from the Office of the Privacy Commissioner of Canada for further information.
Japan
Partial adequacy - only covers personal data transferred to private sector organisations subject to Japan’s Act on the Protection of Personal Information. This does not include transfers of the types listed in the EU’s adequacy decision for Japan.
United States of America
Partial adequacy - only covers data which is transferred under the UK Extension to the EU-US Data Privacy Framework. You can find more information about the UK Extension, including a factsheet for UK organisations, on gov.uk and on the US Department of Commerce’s Data Privacy Framework Program website.
|
Country |
Data access status |
Data access status |
Adequacy decision |
|---|---|---|---|
Afghanistan |
Not accepted |
N/A |
N/A |
Andorra |
Accepted |
Accepted |
European Commission’s adequacy decision |
Australia |
Accepted |
Accepted |
None – IDTA required |
Austria |
Accepted |
Accepted |
EEA (EU) |
Argentina |
Accepted |
Accepted |
European Commission’s adequacy decision |
Belarus |
Not accepted |
N/A |
N/A |
Belgium |
Accepted |
Accepted |
EEA (EU) |
Bosnia and Herzegovina |
Not accepted |
N/A |
N/A |
Bulgaria |
Accepted |
Accepted |
EEA (EU) |
Burundi |
Not accepted |
N/A |
N/A |
Canada |
Accepted |
Accepted |
IDTA may be required |
Central African Republic |
Not accepted |
N/A |
N/A |
China, People’s Republic of (including Macau) |
Not accepted |
N/A |
N/A |
Congo, Democratic Republic of |
Not accepted |
N/A |
N/A |
Crimea, Autonomous Republic of (Crimea Region of Ukraine) |
Not accepted |
N/A |
N/A |
Croatia |
Accepted |
Accepted |
EEA (EU) |
Cuba |
Not accepted |
N/A |
N/A |
Cyprus |
Accepted |
Accepted |
EEA (EU) |
Czech Republic |
Accepted |
Accepted |
EEA (EU) |
Denmark |
Accepted |
Accepted |
EEA (EU) |
Egypt |
Accepted |
Requires review by NHS England |
None - IDTA required |
Estonia |
Accepted |
Accepted |
EEA (EU) |
EU or EEA institutions, bodies, offices, or agencies |
Accepted |
Accepted |
EEA |
Faroe Islands |
Accepted |
Accepted |
European Commission’s adequacy decision |
Finland |
Accepted |
Accepted |
EEA (EU) |
France |
Accepted |
Accepted |
EEA (EU) |
Germany |
Accepted |
Accepted |
EEA (EU) |
Gibraltar |
Accepted |
Accepted |
UK adequacy decision |
Greece |
Accepted |
Accepted |
EEA |
Guernsey |
Accepted |
Accepted |
European Commission’s adequacy decision |
Guinea, Republic of |
Not accepted |
N/A |
N/A |
Guinea-Bissau, Republic of |
Not accepted |
N/A |
N/A |
Haiti |
Not accepted |
N/A |
N/A |
Hong Kong |
Not accepted |
N/A |
N/A |
Hungary |
Accepted |
Accepted |
EEA (EU) |
Iceland |
Accepted |
Accepted |
EEA (EFTA) |
Iran |
Not accepted |
N/A |
N/A |
Iraq |
Not accepted |
N/A |
N/A |
Ireland |
Accepted |
Accepted |
EEA (EU) |
Isle of Man |
Accepted |
Accepted |
European Commission’s adequacy decision |
Israel |
Accepted |
Accepted |
European Commission’s adequacy decision |
Italy |
Accepted |
Accepted |
EEA (EU) |
Japan |
Accepted |
Accepted |
IDTA may be required |
Jersey |
Accepted |
Accepted |
European Commission’s adequacy decision |
Kenya |
Accepted |
Accepted |
None – IDTA required |
Korea, Democratic People’s Republic of (North Korea) |
Not accepted |
N/A |
N/A |
Korea, Republic of (South Korea) |
Accepted |
Accepted |
UK adequacy decision |
Latvia |
Accepted |
Accepted |
EEA (EU) |
Lebanon |
Not accepted |
N/A |
N/A |
Libya |
Not accepted |
N/A |
N/A |
Liechtenstein |
Accepted |
Accepted |
EEA (EFTA) |
Lithuania |
Accepted |
Accepted |
EEA (EU) |
Luxembourg |
Accepted |
Accepted |
EEA (EU) |
Mali |
Not accepted |
N/A |
N/A |
Malta |
Accepted |
Accepted |
EEA (EU) |
Moldova |
Not accepted |
N/A |
N/A |
Myanmar, Republic of the Union of |
Not accepted |
N/A |
N/A |
Netherlands |
Accepted |
Accepted |
EEA (EU) |
New Zealand |
Accepted |
Accepted |
European Commission’s adequacy decision |
Nicaragua |
Not accepted |
N/A |
N/A |
Norway |
Accepted |
Accepted |
EEA (EFTA) |
Poland |
Accepted |
Accepted |
EEA (EU) |
Portugal |
Accepted |
Accepted |
EEA (EU) |
Romania |
Accepted |
Accepted |
EEA (EU) |
Russia |
Not accepted |
N/A |
N/A |
Slovakia |
Accepted |
Accepted |
EEA (EU) |
Slovenia |
Accepted |
Accepted |
EEA (EU) |
Somalia |
Not accepted |
N/A |
N/A |
South Sudan |
Not accepted |
N/A |
N/A |
Spain |
Accepted |
Accepted |
EEA (EU) |
Sudan |
Not accepted |
N/A |
N/A |
Sweden |
Accepted |
Accepted |
EEA (EU) |
Switzerland |
Accepted |
Accepted |
European Commission’s adequacy decision |
Syria |
Not accepted |
N/A |
N/A |
Taiwan |
Not accepted |
N/A |
N/A |
Turkey |
Accepted |
Requires review by NHS England |
None - IDTA required |
Ukraine |
Not accepted |
N/A |
N/A |
Uruguay |
Accepted |
Accepted |
European Commission’s adequacy decision |
United Arab Emirates |
Not accepted |
N/A |
N/A |
United States of America |
Accepted |
Accepted |
IDTA may be required |
Venezuela |
Not accepted |
N/A |
N/A |
Yemen |
Not accepted |
N/A |
N/A |
Zimbabwe |
Not accepted |
N/A |
N/A |
Updated: 13 October 2026